Landscapes / Companies
AvenCell Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 27 Apr 2029Phase 1/2 trial completes | |||
| Next date | 27 Apr 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021